The University Of Texas Health Science Center At San Antonio

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis

Withdrawn

Conditions: Colitis
Colon Cancer

First Posted Date: 2017-01-09

Last Posted Date: 2018-09-17

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Registration Number: NCT03014284

Locations: 🇺🇸
Cancer Therapy & Research Center at UTHSCSA, San Antonio, Texas, United States

MLN8237 for a Subject With Adenocarcinoma of the Prostate

Conditions: Prostate Cancer

First Posted Date: 2016-12-29

Last Posted Date: 2018-04-04

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Registration Number: NCT03005262

Breast, Omega 3 Free Fatty Acid, Ph 0

Not Applicable

Completed

Conditions: Breastcancer

Interventions: Dietary Supplement: Omega-3 FFA

First Posted Date: 2016-12-19

Last Posted Date: 2021-03-17

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 21

Registration Number: NCT02996240

Locations: 🇺🇸
CTRC at University of Texas Health Science Center San Antonio, San Antonio, Texas, United States

Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin

Phase 3

Completed

Conditions: Type II; Diabetes

Interventions: Drug: Dapagliflozin
Drug: Placebo

First Posted Date: 2016-12-07

Last Posted Date: 2019-12-18

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 30

Registration Number: NCT02984644

Locations: 🇺🇸
University of Texas Health Science Center, San Antonio, Texas, United States

Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects

Phase 4

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Placebo
Drug: Dapagliflozin

First Posted Date: 2016-12-05

Last Posted Date: 2024-03-04

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 32

Registration Number: NCT02981966

Locations: 🇺🇸
University of Texas Health Science Center, San Antonio, Texas, United States

Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM

Phase 4

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Placebo
Drug: Exenatide
Drug: Dapagliflozin

First Posted Date: 2016-12-02

Last Posted Date: 2023-07-20

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 90

Registration Number: NCT02981069

Locations: 🇺🇸
University of Texas Health Science Center, San Antonio, Texas, United States

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

Not Applicable

Recruiting

Conditions: Diabetes Mellitus, Type 2
Impaired Fasting Glucose (IFG)
Impaired Glucose Tolerance (IGT)

Interventions: Drug: Dapagliflozin
Drug: Pioglitazone
Drug: Metformin
Drug: Saxagliptin

First Posted Date: 2016-11-21

Last Posted Date: 2024-08-07

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 700

Registration Number: NCT02969798

Locations: 🇺🇸
The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

The Effects of Nicotinamide Adenine Dinucleotide (NAD) on Brain Function and Cognition

Not Applicable

Completed

Conditions: Mild Cognitive Impairment
NAD

Interventions: Dietary Supplement: Nicotinamide riboside
Dietary Supplement: Sugar Pill

First Posted Date: 2016-10-24

Last Posted Date: 2021-09-02

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 46

Registration Number: NCT02942888

Locations: 🇺🇸
University of Texas Health San Antonio, San Antonio, Texas, United States
🇺🇸
South Texas Veterans Healthcare System (STVHCS), San Antonio, Texas, United States

Women's Mammography Study to Improve Comfort During Mammography

Not Applicable

Completed

Conditions: Pain

Interventions: Other: Lidocaine
Other: Calming Music
Other: No Music

First Posted Date: 2016-10-05

Last Posted Date: 2022-10-12

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 251

Registration Number: NCT02924441

Locations: 🇺🇸
UT Health Cancer Center, San Antonio, Texas, United States

Clinical Efficacy in Relieving Dentin Hypersensitivity of Nanohydroxyapatite-Containing Toothpastes and Cream

Phase 2

Completed

Conditions: Dentin Sensitivity

Interventions: Drug: Control toothpaste containing Novamin® technology
Drug: Control toothpaste containing 1500 ppm fluoride as MFP
Drug: Test toothpaste with nano-HAP (high concentration)
Drug: Test toothpaste with nano-HAP (low concentration)
Drug: Test toothpaste with nano-HAP and (Potassium Nitrate) KNO3
Drug: Control toothpaste without nano-HAP
Drug: Test toothpaste with nano-HAP (medium concentration)
Drug: Test cream with nano-HAP (higher concentration)
Drug: Control cream without nano-HAP

First Posted Date: 2016-09-29

Last Posted Date: 2018-11-16

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 203

Registration Number: NCT02918617

Locations: 🇺🇸
School of Dentistry, University of Texas Health Science Center, San Antonio, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy